Mint Business News - Official Channel
115K subscribers
10.7K photos
340 videos
7 files
20.3K links
News and analysis from the world of business and finance.

For more, visit
www.livemint.com
Download Telegram
Mounjaro's rapid rise is a testament to the growing demand for effective diabetes and obesity treatments in India, where around 101 million people – 11.4 percent of the country's population – live with diabetes, as per a 2023 Lancet study.

But what is the drug and what are the side impacts? Is it even worth it?
WATCH: https://www.youtube.com/watch?v=ZsMBkxuADUw
2🤔1
📈 MARKETS OPEN FLAT WITH A POSITIVE BIAS
Sensex starts higher, up 257 pts at 83,473, while Nifty holds steady around 25,492.
Investors await global cues and key earnings later in the day.

Track all market updates here 👇
https://www.livemint.com/market
5
Mint Long Story | Nitish Kumar’s two-decade rule is his strength and weakness, with visible infrastructure gains clashing with public exhaustion and his failure to tackle outward migration. Voters are now divided between memory of ‘jungle raj’ and yearning for ‘badlaav’ (change).

Read more: https://livemint.com/politics/bihar-polls-nitish-vs-fatigue-tejashwi-jobs-11762769973816.html
7😁1